Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

OptimizeRx Q2 2024 Adj. EPS $0.02 Beats $(0.06) Estimate, Sales $18.812M Miss $20.195M Estimate

Author: Benzinga Newsdesk | August 08, 2024 04:59pm
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.06) by 133.33 percent. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $18.812 million which missed the analyst consensus estimate of $20.195 million by 6.85 percent. This is a 36.14 percent increase over sales of $13.818 million the same period last year.

Posted In: OPRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist